Liver and tumour tissue concentrations of TNF-α in cancer patients treated with TNF-α and melphalan by isolated liver perfusion

British Journal of Cancer

Volumn 75, Issue 10, 1997, Pages 1497-1500

  Kuppen, P J K ^a,c   Jonges, L E ^a   Van De Velde, C J H ^a   Vahrmeijer, A L ^a   Tollenaar, R A E M ^a   Borel Rinkes, I H M ^b   Eggermont, A M M ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c K6 R ^*  (Netherlands)

Author keywords

ELISA; Isolated liver perfusion; Liver metastases; TNF

Indexed keywords

MELPHALAN; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER TISSUE; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; ISOLATED LIVER; LIVER; LIVER TOXICITY; MALE; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL;

EID: 0030987226     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.255     Document Type: Article

References (17)

1. Adamson GM and Billings RE (1992) Tumor necrosis factor induced oxidative stress in isolated mouse hepatocytes. Arch Biochem Biophys 294: 223-229
2. Alexander RB and Rosenberg SA (1991) Tumor necrosis factor: clinical applications. In Biologic therapy of cancer, De Vita Jr VT, Hellman S and Rosenberg SA. (eds), pp. 378-392. JB Lippincott: Philadelphia
3. Blick M, Sherwin SA, Rosenblum M and Gutterman J (1987) Phase I study of recombinant tumor necrosis factor in cancer patients. Cancer Res 47: 2986-2989
4. Cid MC, Kleinman HK, Grant DS, Schnaper HW, Fauci AS and Hoffman GS (1994) Estradiol enhances leukocyte binding to tumor necrosis factor (TNF)-stimulated endothelial cells via an increase in TNF-induced adhesion molecules E-selectin, intercellular adhesion molecule type 1, and vascular cell adhesion molecule type 1. J Clin Invest 93: 17-25
5. Feinberg B, Kurzrock R, Talpaz M, Blick M, Saks S and Gutterman JU (1988) A phase I trial of intravenously-administered recombinant tumor necrosis factor-alpha in cancer patients. J Clin Oncol 6: 1328-1334
6. Heller RA and Krönke M (1994) Tumor necrosis factor receptor-mediated signaling pathways. J Cell Biol 126: 5-9
7. Hieber U and Heim ME (1994) Tumor necrosis factor for the treatment of malignancies. Oncology 51: 142-153
8. Jäättelä M (1991) Biologic activities and mechanisms of action of tumor necrosis factor-α/cachectin. Lab Invest 64: 724-742
9. Klaase JM, Kroon BBR, Eggermont AMM, Van Geel AN, Schraffordt Koops H, Oldhoff J, Liénard D, Lejeune FJ, Berkel R, Franklin HR and Hart AAM (1995) A retrospective comparative study evaluating the results of mild hyperthermic versus controlled normothermic perfusion for recurrent melanoma of the extremities. Eur J Cancer 31A: 58-63
10. Lejeune F, Liénard D, Eggermont A, Schraffordt Koops H, Rosenkaimer F, Gérain J, Klaase J, Kroon B, Vanderveken J and Schmitz P (1994) Rationale for using TNF-α and chemotherapy in regional therapy of melanoma. J Cell Biochem 56: 52-61
11. Lienard D, Ewalenko P, Delmotte J-J, Renard N and Lejeune FJ (1992) High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma. J Clin Oncol 10: 52-60
12. McIntosh JK, Mulé JJ, Merino MJ and Rosenberg SA (1988) Synergistic antitumor effects of immunotherapy with recombinant interleukin-2 and recombinant tumor necrosis factor-α. Cancer Res 48: 4011-4017
13. Prince WS, Harder KJ, Saks S, Reed BR, Chen AB and Jones AJS (1987) ELISA for quantitation of tumor necrosis factor-α in serum. J Pharm Biomed Anal 5: 793-802
14. Renard N, Liénard D, Lespagnard L, Eggermont AMM, Heimann R and Lejeune F (1994) Early endothelium activation and polymorphonuclear cell invasion precede specific necrosis of human melanoma and sarcoma treated by intravascular high-dose tumour necrosis factor alpha (rTNFα). Int J Cancer 57: 656-663
15. Spriggs DR (1991) Tumor necrosis factor: basic principles and preclinical studies. In Biologic therapy of cancer, De Vita Jr VT, Hellman S and Rosenberg SA. (eds), pp. 354-377. JB Lippincott: Philadelphia
16. Vahrmeijer AL, van Dierendonck JH and Van de Velde CJH (1995) Treatment of colorectal cancer metastases confined to the liver. Eur J Cancer 31A: 1238-1242
17. Zimmerman RJ, Chan A and Leadon SA (1989) Oxidative damage in murine tumor cells treated in vitro by recombinant human tumor necrosis factor. Cancer Res 49: 1644-1648